DocGo Inc. provided earnings for the year 2022. The company sees strong demand from customers for both mobile health and transportation services and anticipates 2022 revenue to be approximately $400 million to $420 million, representing growth of 27%-32% over 2021, or a 65% increase if exclude non-recurring Covid testing revenue from the second half of both years.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.085 USD | -4.19% | +4.95% | -44.99% |
05-09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
05-09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.99% | 327M | |
-3.43% | 2.99B | |
0.00% | 1.97B | |
+64.94% | 683M | |
-12.56% | 459M | |
-8.58% | 185M | |
-16.05% | 133M | |
+1.92% | 67.86M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings for the Year 2022